Antibiotics

More advanced planning needed for antimicrobials

Read more

New antibiotics pass regulatory hurdles

Read more

Destiny Pharma advances strategy against bacteria

Read more

Insect-derived peptides - next generation antibiotics?

Read more

Time for action against antimicrobial resistance

Read more

Exploring new business models for antibiotics

Read more

Building the antibiotic pipeline

Read more

Meeting Report: Funding rises for early assets

Read more

Sourcing antibiotics from the nematode worm

Read more

Assessing the threat from drug-resistant bacteria

Read more